Industry
Guides, insights, and resources for peptide researchers
IndustryApril 23, 2026
FDA Removes 12 Peptides from Category 2 (April 2026): What the Next Step Means
On 22 April 2026 the FDA formally removed 12 peptides from Category 2. We explain why that does not automatically unlock compounding access and what the July 2026 PCAC review will decide.
Read more→
IndustryApril 11, 2026
How to Buy Research Peptides in the EU: Payment Options Guide 2026
A practical guide to payment methods when buying research peptides in Europe. Compare credit card, SEPA and crypto options.
Read more→
IndustryMarch 24, 2026
Peptide Sciences Alternative: EU-Based Vendor with Janoshik-Verified Peptides
Looking for a Peptide Sciences alternative after the March 2026 shutdown? Peptides Direct offers Janoshik-verified research peptides with fast EU shipping.
Read more→
IndustryMarch 21, 2026
US Peptide Regulation 2026: What the FDA Changes Mean for EU Researchers
The FDA landscape for peptides has shifted significantly. This article explains the Category 1 and 2 system, the February 2026 reclassification.
Read more→
IndustryMarch 9, 2026
Why Researchers Are Looking More Closely at EU Peptide Vendors
A measured look at why some researchers are shifting peptide sourcing toward Europe, including regulatory context, logistics, testing, and data privacy.
Read more→
IndustryMarch 9, 2026
Peptide Sciences Website Down: What EU Researchers Need to Know
Peptide Sciences appeared unavailable in March 2026. Here is what can be verified, how recent FDA peptide policy should be understood.
Read more→
FOR RESEARCH USE ONLY. The information provided in these articles is for educational and research purposes only. Not intended as medical advice. All products are sold strictly for in-vitro research and laboratory use.